Merck reports strong new HIV study results showing non-inferiority of DOR/ISL to Gilead's Biktarvy and secures an EU approval ...
Rahway, New Jersey Thursday, November 20, 2025, 14:00 Hrs [IST] ...
Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a ...
The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
Akeso has a validated process in place for developing antibodies but does require US exposure to meet its lofty valuation.
One of the teams is trying to combine mRNA vaccine with ultrasound technology to treat deadly pancreatic cancer.
Researchers advance mRNA cancer therapies as France tests new methods, while the FDA approves Bayer’s Hyrnuo for HER2-mutated ...
Jefferies London Healthcare Conference 2025 November 20, 2025 9:30 AM ESTCompany ParticipantsPeter Dannenbaum - Vice ...
While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the ...
Investor's Business Daily on MSN
Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.
Targeted chemotherapy is here. So-called antibody drug conjugates could flip the toxic paradigm on its ear, helping more ...
The process of TIL therapy is complex and requires the coordination of multiple specialties at authorized treatment centers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback